Intercept Pharmaceuticals, Inc.
(NASDAQ : ICPT)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -0.09%26.6614.1%$156.87m
HZNPHorizon Therapeutics Plc 0.39%77.735.6%$140.97m
ACRSAclaris Therapeutics, Inc. 1.00%18.224.7%$139.55m
CTLTCatalent, Inc. -1.20%116.862.1%$104.47m
BHCBausch Health Cos., Inc. -0.09%26.660.0%$101.20m
JAZZJazz Pharmaceuticals Plc 1.74%168.652.4%$87.66m
ACSTAcasti Pharma, Inc. -4.17%0.800.2%$62.44m
UTHRUnited Therapeutics Corp. 0.34%167.7114.1%$60.99m
ISRIsoRay, Inc. -7.88%2.222.5%$60.19m
GWPHGW Pharmaceuticals Plc 2.37%141.706.1%$50.90m
AMRNAmarin Corp. Plc 3.80%6.551.5%$50.78m
PRGOPerrigo Co. Plc -0.29%43.306.8%$50.66m
ARGXargenx SE -1.37%310.980.0%$50.51m
TNXPTonix Pharmaceuticals Holding Corp. 5.10%1.030.2%$44.38m
SAGESAGE Therapeutics, Inc. -4.21%88.557.6%$42.82m

Company Profile

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.